Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2003
11/06/2003US20030207419 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207418 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207417 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207416 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207415 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207414 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207411 DNA sequence encoding enzymes of clavulanic acid biosynthesis
11/06/2003US20030207410 Process for the biological production of l-pipecolic acid
11/06/2003US20030207406 Method of transferring at least two saccharide units with a polyglycosyltransferase
11/06/2003US20030207405 Reacting a sugar phosphate and cytosine or cytosine derivative in the presence of an enzyme having the activity of cytosine nucleoside phosphorylase; given amino acid sequence; little by-product
11/06/2003US20030207403 For diagnosis or treatment of diseases with beta 10 polypeptides and alpha 2/ beta 10 heterodimers or their respective binding agents, such as thyroid gland disorders
11/06/2003US20030207401 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207400 Double stranded DNA of target sequence(s) bound non-covalently to a sequence specific polyamide (SSP) moiety having a ligand moiety linked covalently to said polyamide; polyamide contains N-methylpyrrole or N-methylimidazole groups
11/06/2003US20030207399 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207397 For pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207396 For pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207395 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207391 Used to prevent dimerisation of vascular endothelial growth factor (VEGF)
11/06/2003US20030207390 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207389 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207388 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207387 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207386 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207385 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207384 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207383 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207382 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207381 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207380 For diagnosis and treatment of estrogenic disorder of mutant ER alpha
11/06/2003US20030207379 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207378 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207377 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207376 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207374 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207373 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207371 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207370 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207369 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207368 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207367 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207366 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207365 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207364 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207363 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207362 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207361 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207360 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207359 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207358 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207357 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207356 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207355 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207354 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207353 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207352 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207351 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207350 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207349 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207347 Useful in treating ovarian, renal, neurological, cardiovascular disorders and modulating angiogenesis, cell proliferation
11/06/2003US20030207345 Oxygenase enzymes and screening method
11/06/2003US20030207341 Methods for determining compounds capable of inhibiting the activities of the Ha-ras oncogene
11/06/2003US20030207339 PCAM-1 marker protein, nucleic acid sequences encoding PCAM-1 and immunoassays for detection of PCAM-1
11/06/2003US20030207334 25312, a novel human agmatinase-like homolog
11/06/2003US20030207330 Fibrinogen binding moieties
11/06/2003US20030207328 Analyte assay using particulate labels
11/06/2003US20030207322 Nucleic acid encoding toluene monooxygenase enzyme pathway; transformed host cells for biosynthesis of p-hydroxybenzoic acid
11/06/2003US20030207319 Novel human kinases and polynucleotides encoding the same
11/06/2003US20030207318 Kinesin-like motor protein
11/06/2003US20030207317 Novel nucleic acid isolated from Tetrahymena which codes for a triterpenoid cyclase, its production, and use
11/06/2003US20030207309 Diagnostics and therapeutics for macular degeneration-related disorders
11/06/2003US20030207305 Nitro-substituted non-fluorescent asymmetric cyanine dye compounds
11/06/2003US20030207303 Method and kit for determining human geographic or population origin
11/06/2003US20030207301 Assay for the detection of factors that modulate the expression of INGAP
11/06/2003US20030207299 Involves nucleic acid and amino acid sequences of human kinases; used in the diagnosis, treatment, and prevention of cancer, immune disorders, disorders affecting growth and development, cardiovascular diseases, and lipid disorders
11/06/2003US20030207298 Method for detecting target plant genus
11/06/2003US20030207294 Method for analysing immunodeficiency virus (HIV) phenotypic characteristics
11/06/2003US20030207293 Cryptic-like secreted protein
11/06/2003US20030207290 Methods, reagents, kits and apparatus for protein function analysis
11/06/2003US20030207287 Non-stochastic generation of genetic vaccines
11/06/2003US20030207286 Nucleic acid sequences showing enhanced expression in benign neuroblastoma compared with acritical human neuroblastoma
11/06/2003US20030207283 Isolated polynucleotide encoding a novel phosphate transporter in plants and a method of modulating phosphate uptake in plants
11/06/2003US20030207279 Using polymerase chain reaction
11/06/2003US20030207269 High throughput gene expression for drug discovery
11/06/2003US20030207267 Multiply-primed amplification of nucleic acid sequences
11/06/2003US20030207266 Thermal cycling protocol for nucleic acid amplification uses two primers with different thermal melting temperatures
11/06/2003US20030207264 Use of a single fluorophore rather than an "acceptor-donor" fluoresecence resonance energy transfer system offers synthesis and performance advantages; fluorogenic protease indicators
11/06/2003US20030207263 Method of screening therapeutic agents
11/06/2003US20030207262 Compounds, methods of screening, and in vitro and in vivo uses involving anti-apoptotic genes and anti-apoptotic gene products
11/06/2003US20030207260 Contacted with probe that hybridizes one complementary sequence
11/06/2003US20030207259 By transfecting cellular DNA into cells
11/06/2003US20030207251 For drug screening
11/06/2003US20030207248 Across biological membranes of living cells; screening test chemicals that modulate a target ion channel; using fluorescence resonance energy transfer (FRET)
11/06/2003US20030206927 Methods for isolating and using fungal hemolysins
11/06/2003US20030206926 Characterized by the loss of its capability to reproductively replicate in human cell lines.
11/06/2003US20030206925 Isolated, recombinantly-generated, negative-sense, single-stranded RNA viruses having one or more mutations and/or deletions which reduce repression normally caused by V protein
11/06/2003US20030206919 Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
11/06/2003US20030206917 Transferring a protein to a cell by coating the cell surface with a lipidated protein; and contacting said cell with a fusion protein having affinity for said lipidated protein and capable of binding to a cell surface receptor
11/06/2003US20030206910 Poloxamer 188, Poloxamer 237, Poloxamer 338, Poloxamer 124, Poloxamer 401, Tetronic 904, Tetronic 908, Tetronic 1107 or Tetronic 90R4; especially for treating chronic hepatitis and cancer
11/06/2003US20030206901 Detection of adhesion of cancer cells to a matrix coated with adhesion molecules; inhibiting the metastatic activity by administration of a dipeptidyl peptidase IV inhibitor.
11/06/2003US20030206900 Vectors derived from antibodies for transferring substances into cells
1 ... 2382 2383 2384 2385 2386 2387 2388 2389 2390 2391 2392 2393 2394 2395 2396 2397 2398 2399 2400 2401 2402 ... 4023